Novartis Reported Earlier, Its Phase III HARBOR Study Evaluating Del-Desiran In People Living With Myotonic Dystrophy Type 1 Did Not Meet Primary Endpoint

뉴스 본문을 불러오고 있어요.

Novartis Reported Earlier, Its Phase III HARBOR Study Evaluating Del-Desiran In People Living With Myotonic Dystrophy Type 1 Did Not Meet Primary Endpoint | 웨이프 WAPE

Novartis Reported Earlier, Its Phase III HARBOR Study Evaluating Del-Desiran In People Living With Myotonic Dystrophy Type 1 Did Not Meet Primary Endpoint

기사 요약

관련 종목

댓글 —